High anti-HEV IgG seroprevalence was reported in German patients with GBS (41%); the rate of recent HEV infection, which the authors defined as anti-HEV IgM(+)/IgG(+)/RNA(−) status, was 1.2% [28]. Here, CD40LG is linked to Guillain-Barre syndrome.